In 2017, every woman in Australia aged 37 years and younger is already better protected against HPV than ever before – this is a huge milestone and a truly remarkable feat. How was this achieved and what hurdles still exist? Find out in this exclusive opinion piece.
In this patient perspective article, you can find out about the challenges associated with diagnosing mesothelioma and the promising role that biomarkers are playing.
Targeted sequencing focused on cancer-related genes provides comprehensive assessment of tumor mutational burden, with results comparable to whole-exome sequencing.
In this blog piece from our charity partner World Cancer Research Fund, Rachel Thompson tells us about the link between alcohol consumption and breast cancer.
Find out about how the UK’s National Physical Laboratory (NPL) is enabling greater confidence in radiotherapy, leading to accelerated implementation of the most advanced techniques and helping to ensure patients receive the same standard of treatment irrespective of where they receive their treatment.
To mark our focus on social media in cancer care we recently spoke with Deanna Attai from the University of California (CA, USA) about the potential use of social media in cancer care including how oncologists can incorporate social media into their care plans as well as the opportunities and risks they should be aware of
Armed with over 10 years of positive EU experience, a significant logical and well-founded evolution is underway with biosimilar medicines offering great benefits for all involved in the healthcare system. Julie Maréchal-Jamil from Biosimilar Medicines group (a Medicines for Europe sector group) explains.